Fingolimod for Type 2 Diabetes Mellitus

Summary

The aim of this study is to explore the efficacy and safety of Fingoland in the treatment of type 2 diabetes. A total of 40 patients were randomly divided into two groups. One group was treated with fingolimod, another group was given guideline based treatment. The changes of islet function in patients with glycosylated hemoglobin, insulin and C-peptide were observed .

Timeline

Start

2022-03-15

Primary completion

2026-03-15

Completion

2026-03-15

Drugs

Indications